CD8A and neoplasm: The activated CD44hiCD62lo CD8+ TIL population was slightly decreased by IL-2 and S4B6-1 administration (Supplemental Figure 14B), consistent with progressive tumor growth (Supplemental Figure 14F and Supplemental Table 7).